Purchase Order 75N93022P00284
Award Date
1/19/22
Potential Completion Date
1/18/23
Potential Value
$148K
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Speed Biosystems, LLC
Ultimate Awardee
Not listed
NAICS Category
325413 - In-Vitro Diagnostic Substance Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Potomac, MD 20854, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price purchase order contract awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Speed Biosystems, LLC, a minority-owned, small disadvantaged business, for the provision of TURBO293 transfection reagents, kits, protocols, and continuity support to aid coronavirus-related research at NIH labs and the Vaccine Research Center. The $146,600.00 contract was...
This contract is a firm fixed price purchase order awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Speed Biosystems, LLC, a minority-owned small disadvantaged business, for the provision of TURBO293 transfection reagents. The potential value of the contract is $146,750.00. The contract was sole-sourced to Speed Biosystems as the proprietary developer of the TURBO293 reagents, which...
The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases (NIAID) awarded a firm fixed-price purchase order contract to Speed Biosystems, LLC, a minority-owned small disadvantaged business, to provide 70 units of TURBO293 transfection reagent at a potential value of $146,750.00. The contract supports COVID-19 research and vaccine production activities at NIH labs in Maryland. This sole-source award was made under the...
This is a sole source, firm-fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Speed Biosystems, LLC. The $143,875.00 award is for the supply of 45 units of TURBO293 Transfection Reagent (20ML), a proprietary product used in coronavirus-related research, vaccine production, and the development of immunogens and antibodies for SARS-CoV-2 clinical trials. Speed Biosystems is the sole...
The Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) awarded a firm-fixed-price purchase order to Speed Biosystems, LLC, a minority-owned small disadvantaged business, for the provision of TURBO293 transfection reagents. The $248,980.00 contract supports coronavirus-related research at NIH labs and the Vaccine Research Center. The award was sole-sourced to Speed Biosystems as the proprietary developer of...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed price purchase order to Speed Biosystems, LLC, a minority-owned small disadvantaged business, to procure 50 units of the TURBO293 Transfection Reagent for $146,600.00. The award was made on a sole-source basis, as Speed Biosystems is the proprietary developer of the TURBO293 reagents, which are used in vaccine production for human clinical trials....
The Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) awarded a firm-fixed-price purchase order to Speed Biosystems, LLC for the provision of COVID-19 TURBO 293 transfection reagents. The contract, valued at $148,325.00, has a period of performance through June 8, 2023. Speed Biosystems is a minority-owned, small disadvantaged business that has previously received over $3 million in prime federal contracts...
The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) awarded a $222,712.50 firm fixed price purchase order to Speed Biosystems, LLC, a minority-owned small disadvantaged business, for the provision of 75 units of TURBO293 Transfection Reagent (20ML), catalog #PXX1002. This sole-source award was made on July 25, 2022 with a period of performance through July 24, 2023. The contract is not associated with...
This federal contract award was made by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Speed Biosystems, LLC, a minority-owned, small disadvantaged business. The $146,750.00 firm fixed price purchase order is for the delivery of 70 units of Speed Biosystems' proprietary TURBO293 transfection reagent, which is critical for coronavirus-related research, vaccine development, and production of...
This is a sole-source, firm-fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a part of the U.S. Department of Health and Human Services, to Speed Biosystems, LLC, a minority-owned, small disadvantaged business. The $248,980.00 contract is for the delivery of 78 units of TURBO293 Transfection Reagents to support coronavirus research, vaccine production, and immunogen development at NIAID facilities in Maryland. The award is not set aside and...